Information for Pharmacists
Next Choice One Dose™

is a single-pill option that provides effective emergency contraception when taken within 72 hours (3 days) after a sexual encounter has occurred.1

Let Her Know She Has an Option

Facing an unintended pregnancy can be difficult for a woman. As a pharmacist, you may be the only healthcare contact a woman has following an unprotected sexual event that could lead to an unwanted pregnancy. Emergency contraception is one option you may want to discuss with them. Taken in the days immediately following unprotected sex, emergency contraception can reduce the likelihood that a woman will become pregnant.2

With a single dose—and a single pill—Next Choice One Dose™ may give women who are 17 years of age or older the over-the-counter emergency contraception they may need up to 72 hours (3 days) after the event has occurred.1

Patients 17 years of age or older don’t need a prescription to receive Next Choice One Dose™—just a driver’s license or other government-issued proof of age. It is available with a prescription for those younger than 17 years of age.1

Next Choice One Dose™ is bioequivalent to Plan B One-Step®.3

Important Safety Information

Next Choice One Dose™ is a progestin-only emergency contraceptive indicated for prevention of pregnancy after unprotected intercourse or known or suspected contraceptive failure. Next Choice One Dose™ is only available without a prescription for women 17 years of age or older. Women younger than 17 years of age require a prescription. Next Choice One Dose™ is contraindicated for use in the case of known or suspected pregnancy. Women who become pregnant or complain of lower abdominal pain after taking Next Choice One Dose™ should be evaluated for an ectopic pregnancy. Next Choice One Dose™ is not effective in terminating an existing pregnancy. If the next expected menses is delayed beyond 1 week after use of Next Choice One Dose™, pregnancy should be considered. Next Choice One Dose™ does not protect against HIV or other sexually transmitted diseases (STDs). Next Choice One Dose™ contains FD&C Yellow #6 as a color additive. The most common adverse reactions in clinical trials included heavier menstrual bleeding (31%), nausea (14%), lower abdominal pain (13%), fatigue (13%), headache (10%), and dizziness (10%). If vomiting occurs within 2 hours of taking Next Choice One Dose™, consideration should be given to repeating the dose.

To report side effects of prescription drugs to the FDA, visit fda.gov/medwatch or call 1-800-FDA-1088.

For more information about Next Choice One Dose™, please call our Medical Communications Department at 1-866-9WATSON or see full Prescribing Information.

References: 1. Next Choice One Dose™ full Prescribing Information, Watson Pharma, Inc. 2012. 2. American College of Obstetricians and Gynecologists. Latest options in EC: a resource guide for health care providers and their patients on emergency contraception. 2009. 3. US Department of Health & Human Services, US Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations (Database). Silver Spring, MD. Available at: http://www.accessdata.fda.gov/scripts/cder/ob/default.cfm. Accessed May 14, 2012.

Registered trademarks are the property of their respective owners.